×

Formulation and delivery of PLGA microspheres

  • US 9,295,689 B2
  • Filed: 05/18/2013
  • Issued: 03/29/2016
  • Est. Priority Date: 12/16/2011
  • Status: Active Grant
First Claim
Patent Images

1. A method of producing a protein of interest in a cell comprising contacting the cell with a PLGA microsphere particle consisting essentially of PLGA and having no amine-containing polymers or amino acids, said PLGA microsphere particle comprising a modified mRNA greater than 30 nucleotides-in length encoding said protein of interest, wherein said modified mRNA consists of nucleoside modifications where 25% of uridine residues are replaced with the nucleoside modification 2-thiouridine and 25% of cytosine residues are replaced with the nucleoside modification 5-methylcytosine and wherein said modified mRNA is formulated in the PLGA microsphere particle such that the PLGA microsphere has a modified mRNA percent encapsulation efficiency of at least 68.1%, a particle size of at least 25 μ

  • m and an actual RNA loading of at least 0.31 weight percent.

View all claims
  • 3 Assignments
Timeline View
Assignment View
    ×
    ×